Carolyn Ho

researcher

Born 2000-01-01

Carolyn Ho is …
instance of (P31):
humanQ5

External links are
P496ORCID iD0000-0002-7334-7924

P69educated atYale UniversityQ49112
Harvard Medical SchoolQ49121
P108employerBrigham and Women's HospitalQ2900977
P735given nameCarolynQ18091370
CarolynQ18091370
P106occupationresearcherQ1650915
P21sex or genderfemaleQ6581072

Reverse relations

author (P50)
Q37504006A clinical approach to inherited hypertrophy: the use of family history in diagnosis, risk assessment, and management.
Q36420143A clinician's guide to tissue Doppler imaging.
Q36511747A contemporary approach to hypertrophic cardiomyopathy.
Q24602132A novel custom resequencing array for dilated cardiomyopathy
Q46506724Advanced assessment of cardiac morphology and prediction of gene carriage by CMR in hypertrophic cardiomyopathy - the HCMNet/UCL collaboration.
Q61897195Assessment of Diastolic Function With Doppler Tissue Imaging to Predict Genotype in Preclinical Hypertrophic Cardiomyopathy
Q34030488Cardiovascular manifestations of Fabry disease: relationships between left ventricular hypertrophy, disease severity, and alpha-galactosidase A activity
Q57841015Clinical Features and Outcome of Hypertrophic Cardiomyopathy Associated With Triple Sarcomere Protein Gene Mutations
Q115579338Clinical characteristics and outcomes in childhood-onset hypertrophic cardiomyopathy
Q33930898Clinical outcome and phenotypic expression in LAMP2 cardiomyopathy
Q37683177Comparison of echocardiographic and cardiac magnetic resonance imaging in hypertrophic cardiomyopathy sarcomere mutation carriers without left ventricular hypertrophy.
Q115579471Discordant clinical features of identical hypertrophic cardiomyopathy twins
Q30480164Echocardiographic strain imaging to assess early and late consequences of sarcomere mutations in hypertrophic cardiomyopathy
Q48604561Effect of radiofrequency catheter ablation of ventricular tachycardia on left ventricular function in patients with prior myocardial infarction
Q37631139Effects of losartan on left ventricular hypertrophy and fibrosis in patients with nonobstructive hypertrophic cardiomyopathy.
Q35549595Electrocardiographic features of sarcomere mutation carriers with and without clinically overt hypertrophic cardiomyopathy.
Q34399188Familial dilated cardiomyopathy caused by an alpha-tropomyosin mutation: the distinctive natural history of sarcomeric dilated cardiomyopathy
Q58087435Faster cross-bridge detachment and increased tension cost in human hypertrophic cardiomyopathy with the R403Q MYH7 mutation
Q50281368Fibrotic content of LV myocardium quantified by CMR characterizes left atrial sizes and total left atrial emptying function incremental to LV functional parameters and LV myocardial mass index in patients with hypertrophic cardiomyopathy
Q28280136Gene mutations in apical hypertrophic cardiomyopathy
Q58087460Gene-specific increase in the energetic cost of contraction in hypertrophic cardiomyopathy caused by thick filament mutations
Q36882310Genetic testing for dilated cardiomyopathy in clinical practice
Q37160655Genetic testing for inherited heart disease
Q61897173Genetic testing in cardiac disease: from bench to bedside
Q30418104Genetics and cardiovascular disease: a policy statement from the American Heart Association.
Q34999606Genetics and clinical destiny: improving care in hypertrophic cardiomyopathy
Q61897170Heart Failure and Genomics
Q94995169Hypertrophic Cardiomyopathy Overview
Q61897156Hypertrophic cardiomyopathy
Q35893667Hypertrophic cardiomyopathy in 2012
Q37766183Hypertrophic cardiomyopathy: preclinical and early phenotype.
Q61897197Linkage of a familial platelet disorder with a propensity to develop myeloid malignancies to human chromosome 21q22.1-22.2
Q43442575Multimodality non-invasive imaging of a coronary cameral fistula.
Q37696227Muscle dysfunction in hypertrophic cardiomyopathy: what is needed to move to translation?
Q34629550Myocardial fibrosis as an early manifestation of hypertrophic cardiomyopathy
Q41836826New Paradigms in Hypertrophic Cardiomyopathy: Insights from Genetics.
Q61897174Novel Locus for an Inherited Cardiomyopathy Maps to Chromosome 7
Q28287468Perturbed length-dependent activation in human hypertrophic cardiomyopathy with missense sarcomeric gene mutations
Q51547073Postinfarction ventricular septal defect with pseudoaneurysm repair after failed percutaneous closure.
Q34543914Prediction of sarcomere mutations in subclinical hypertrophic cardiomyopathy
Q61897151Profound Left Ventricular Remodeling Associated With LAMP2 Cardiomyopathy
Q41543943Results of clinical genetic testing of 2,912 probands with hypertrophic cardiomyopathy: expanded panels offer limited additional sensitivity.
Q91757740Screening children at risk for hypertrophic cardiomyopathy: balancing benefits and harms
Q41511752Short communication: the cardiac myosin binding protein C Arg502Trp mutation: a common cause of hypertrophic cardiomyopathy
Q96130312Study Design and Rationale of EXPLORER-HCM: Evaluation of Mavacamten in Adults With Symptomatic Obstructive Hypertrophic Cardiomyopathy
Q36823735Subtle abnormalities in contractile function are an early manifestation of sarcomere mutations in dilated cardiomyopathy
Q55403546T1 measurements identify extracellular volume expansion in a genotyped hypertrophic cardiomyopathy population with and without left ventricular hypertrophy.
Q37160724T1 measurements identify extracellular volume expansion in hypertrophic cardiomyopathy sarcomere mutation carriers with and without left ventricular hypertrophy
Q41626761The Design of the Valsartan for Attenuating Disease Evolution in Early Sarcomeric Hypertrophic Cardiomyopathy (VANISH) Trial
Q30585056The MedSeq Project: a randomized trial of integrating whole genome sequencing into clinical medicine
Q35845452The diagnosis of hypertrophic cardiomyopathy by cardiovascular magnetic resonance
Q34254460Truncations of titin causing dilated cardiomyopathy.
Q53368381[Clinical spectrum of preclinical hypertrophic cardiomyopathy: characterizing carriers of sarcomere gene mutation].

Search more.